Mental Health Clinics in Corning, CA Accepting Medicare
7 Mental Health Clinics found. Showing 1 - 7
 Joseph Karl Hoffman Counselor - Mental Health Medicare: Medicare Enrolled Practice Location: 3325 Pathway Ct, Corning, CA 96021 Phone: 530-828-5325 |
Tehama County Health Services Agency - Mental Health Division, Corning Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 275 Solano St, Corning, CA 96021 Phone: 530-527-8491 Fax: 530-527-0240 |
Corning Medical Associates Inc Social Worker - Clinical Medicare: Not Enrolled in Medicare Practice Location: 155 Solano St, Corning, CA 96021 Phone: 530-824-4663 Fax: 530-824-5204 |
Corning Medical Associates, Inc Social Worker - Clinical Medicare: Not Enrolled in Medicare Practice Location: 155 Solano St, Corning, CA 96021 Phone: 530-824-4663 Fax: 530-824-5204 |
River Cities Counseling Inc Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 643 Blackburn Ave, Corning, CA 96021 Phone: 530-824-4408 |
Tehama County Health Services Agency - Da Corning Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 275 Solano St, Corning, CA 96021 Phone: 530-824-4890 Fax: 530-824-8443 |
Rolling Hills Clinic Psychologist Medicare: Medicare Enrolled Practice Location: 740 Solano St, Corning, CA 96021 Phone: 530-690-2827 Fax: 530-900-7007 |
News Archive
Experts discuss link between breast milk components, circadian variation, and infant health
The fat content and levels of several key nutrients and hormones in breast milk vary with the mother's circadian rhythm, which may have implications for the timing of breastfeeding and feeding of expressed milk, especially for high-risk infants.
UnitedHealth Group pays annual dividend to shareholders; renews Share Repurchase Program
UnitedHealth Group (NYSE:UNH) announced today that its Board of Directors, at its regular meeting on February 9, 2010, authorized payment of an annual dividend to shareholders for 2010.
Pfizer announces PALOMA-3 trial results in patients with HR+, HER2- metastatic breast cancer
Pfizer Inc. today announced detailed overall survival data from the PALOMA-3 trial, which evaluated IBRANCE (palbociclib) in combination with fulvestrant compared to placebo plus fulvestrant in women with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer whose disease progressed on or after prior endocrine therapy.
Health law adds to financial squeeze for rural hospitals
The Wall Street Journal reports on how a number of policies and market forces are combining to put added pressure on rural hospitals. Meanwhile, other news outlets report on the challenge of making the health system affordable and the health law's new options for pregnant women.
Study examines two primary treatments for bilateral cleft lip and palate
It may look the same, but it doesn't chew the same. Different dental treatment options for bilateral cleft lip and palate may result in similar aesthetic appearance, but they produce definite differences in jaw function. People with clefts of the lip and palate often have dental anomalies as well. The number, shape, and position of teeth can be affected. In particular, the permanent lateral incisor is frequently absent or misshapen.
› Verified 6 days ago